The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Fragile X Mental Retardation Protein Regulates Protein Expression and mRNA Translation of the Potassium Channel Kv4.2
Open accessAbstract
A prominent characteristic of the inherited intellectual impairment disease fragile X syndrome (FXS) is neuronal hyperexcitability, resulting in a variety of symptoms, such as hyperactivity, increased sensitivity to sensory stimuli, and a high incidence of epileptic seizures. These symptoms account for a significant part of the disease pattern, but the underlying molecular mechanisms of neuronal hyperexcitability in FXS remain poorly understood. FXS is caused by loss of expression of fragile X mental retardation protein (FMRP), which regulates synaptic protein synthesis and is a key player to limit signaling pathways downstream of metabotropic glutamate receptors 1/5 (mGlu1/5). Recent findings suggest that FMRP might also directly regulate voltage-gated potassium channels. Here, we show that total and plasma membrane protein levels of Kv4.2, the major potassium channel regulating hippocampal neuronal excitability, are reduced in the brain of an FXS mouse model. Antagonizing mGlu5 activity with 2-methyl-6-(phenylethynyl)-pyridine (MPEP) partially rescues reduced surface Kv4.2 levels in Fmr1 knock-out (KO) mice, suggesting that excess mGlu1/5 signal activity contributes to Kv4.2 dysregulation. As an additional mechanism, we show that FMRP is a positive regulator of Kv4.2 mRNA translation and protein expression and associates with Kv4.2 mRNA in vivo and in vitro . Our results suggest that absence of FMRP-mediated positive control of Kv4.2 mRNA translation, protein expression, and plasma membrane levels might contribute to excess neuronal excitability in Fmr1 KO mice, and thus imply a potential mechanism underlying FXS-associated epilepsy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Indeed, FMRP is not only involved in translational repression, it is also a translational enhancer (Bechara et al., 2009; Gross et al., 2011; Kwan et al., 2012; Tabet et al., 2016)”
From New insights into the regulatory function of CYFIP1 in the context of WAVE- and FMRP-containing complexes (2017) · cites this paper as Gross et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reinsertion or Degradation of AMPA Receptors Determined by Activity-Dependent Endocytic Sorting
Ehlers, M. D. (2000) · Neuron · doi:10.1016/s0896-6273(00)00129-x · Cited by 1,096
Fragile X Syndrome: Loss of Local mRNA Regulation Alters Synaptic Development and Function
Bassell, G. J., & Warren, S. T. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.004 · Cited by 1,051
Self-citationCorrection of Fragile X Syndrome in Mice
Dölen, G., Osterweil, E., Rao, B. S. S., Smith, G. B., Auerbach, B. D., Chattarji, S., & Bear, M. F. (2007) · Neuron · doi:10.1016/j.neuron.2007.12.001 · Cited by 979
Zalfa, F., Giorgi, M., Primerano, B., Moro, A., Di Penta, A., Reis, S., Oostra, B., & Bagni, C. (2003) · Cell · doi:10.1016/s0092-8674(03)00079-5 · Cited by 676
Advances in the Treatment of Fragile X Syndrome
Hagerman, R. J., Berry-Kravis, E., Kaufmann, W. E., Ono, M. Y., Tartaglia, N., Lachiewicz, A., Kronk, R., Delahunty, C., Hessl, D., Visootsak, J., et al. (2009) · Pediatrics · doi:10.1542/peds.2008-0317 · Cited by 596
Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP
Yan, Q. J., Rammal, M., Tranfaglia, M., & Bauchwitz, R. P. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.06.004 · Cited by 521
Muddashetty, R. S., Kelić, S., Gross, C., Xu, M., & Bassell, G. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0937-07.2007 · Cited by 421
Self-citationAntar, L. N., Afroz, R., Dictenberg, J. B., Carroll, R. C., & Bassell, G. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0099-04.2004 · Cited by 411
Self-citationStructure and Function of Kv4-Family Transient Potassium Channels
Birnbaum, S. G., Varga, A. W., Yuan, L., Anderson, A. E., Sweatt, J. D., & Schrader, L. A. (2004) · Physiological Reviews · doi:10.1152/physrev.00039.2003 · Cited by 369
Chen, X., Yuan, L., Zhao, C., Birnbaum, S. G., Frick, A., Jung, W. E., Schwarz, T. L., Sweatt, J. D., & Johnston, D. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2667-06.2006 · Cited by 306
Cited by
Sorted by citations
Items 101–160 of 160
Leontiadis, L. J., Trompoukis, G., Tsotsokou, G., Miliou, A., Felemegkas, P., & Papatheodoropoulos, C. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1296235 · Cited by 11
Papatheodoropoulos, C. (2025) · Biology · doi:10.3390/biology14040363 · Cited by 15
Cellular localization of the FMRP in rat retina
Zhang, P.-P., Yao, H., Zha, A., Liu, X.-Y., Fan, K.-Y., Xu, Y., Yuan, H.-Y., Li, L., & Wang, L. (2020) · Bioscience Reports · doi:10.1042/bsr20200570 · Cited by 12
Axonal and presynaptic FMRP: Localization, signal, and functional implications
Wang, X., Sela‐Donenfeld, D., & Wang, Y. (2023) · Hearing Research · doi:10.1016/j.heares.2023.108720 · Cited by 13
Delayed in vitro Development of Up States but Normal Network Plasticity in Fragile X Circuits
Motanis, H., & Buonomano, D. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.13010 · Cited by 13
Single-Cell and Neuronal Network Alterations in an In Vitro Model of Fragile X Syndrome
Moskalyuk, A., Vijver, S. V. D., Verstraelen, P., Vos, W. H. D., Kooy, R. F., & Giugliano, M. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz068 · Cited by 12
Kalmbach, B. E., & Brager, D. H. (2020) · Journal of Neurophysiology · doi:10.1152/jn.00494.2020 · Cited by 11
The role of altered translation in intellectual disability and epilepsy
Malone, T. J., & Kaczmarek, L. K. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102267 · Cited by 12
Treatment of Epilepsy Associated with Common Chromosomal Developmental Diseases
Budișteanu, M., Jurcă, M. C., Papuc, S. M., Focșa, I. O., Riga, D., Riga, S., Jurcă, A. D., & Arghir, A. (2020) · Open Life Sciences · doi:10.1515/biol-2020-0003 · Cited by 12
Ding, Q., Zhang, F., Feng, Y., & Wang, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239327 · Cited by 12
Labno, A., Warrier, A., Wang, S., & Zhang, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084086 · Cited by 12
D’Antoni, S., Spatuzza, M., Bonaccorso, C. M., & Catania, M. V. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105731 · Cited by 11
Hu, J.-H., Malloy, C., Liu, Y., Park, J. M., Pratt, A. E., Welch, M. A., Murphy, J. G., Abebe, D. T., Karlsson, R., Cameron, H. A., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115583 · Cited by 10
Motanis, H., & Buonomano, D. V. (2020) · Scientific Reports · doi:10.1038/s41598-020-71333-y · Cited by 10
Luque, M. A., Morcuende, S., Torres, B., & Herrero, L. (2024) · The Journal of Physiology · doi:10.1113/jp285244 · Cited by 9
Liu, Z., Yang, X., Guo, P., Wang, F., Xia, W., Chen, Y., Zou, M., & Sun, C. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.994166 · Cited by 9
Dwivedi, D., Chattarji, S., & Bhalla, U. S. (2019) · eNeuro · doi:10.1523/eneuro.0217-19.2019 · Cited by 9
Zhang, Q., Liu, Y., Xu, J., Teng, Y., & Zhang, Z. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-4254-8_18 · Cited by 8
Syngap1 Regulates Cortical Circuit Assembly by Controlling Membrane ExcitabilityPreprint
Arora, V., Michaelson, S. D., Aceti, M., Kilinic, M., Miller, C. A., & Rumbaugh, G. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.06.519295 · Cited by 7
A novel bungarotoxin binding site-tagged construct reveals MAPK-dependent Kv4.2 trafficking
Tabor, G. T., Park, J. M., Murphy, J. G., Hu, J.-H., & Hoffman, D. A. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2019.06.007 · Cited by 7
Fragile X Mental Retardation Protein Restricts Small Dye Iontophoresis Entry into Central Neurons
Kennedy, T., & Broadie, K. S. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0723-17.2017 · Cited by 7
Hu, J., Liu, Y., & Hoffman, D. A. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1070305 · Cited by 7
Speigel, I. A., Ma, C. M., Bichler, E. K., Gooch, J. L., & García, P. S. (2019) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004183 · Cited by 7
FMRP Enhances the Translation of 4EBP2 mRNA during Neuronal Differentiation
Yu, J., Woo, Y., Kim, H., An, S., Park, S. K., & Jang, S. K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216319 · Cited by 6
Leontiadis, L. J., Trompoukis, G., Felemegkas, P., Tsotsokou, G., Miliou, A., & Papatheodoropoulos, C. (2023) · Brain Sciences · doi:10.3390/brainsci13111598 · Cited by 6
From circuits to behavior: Amygdala dysfunction in fragile X syndrome
Svalina, M. N., Sullivan, R. M., Restrepo, D., & Huntsman, M. M. (2023) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2023.1128529 · Cited by 6
Rainnie, D. G., Hazra, R., Dabrowska, J., Guo, J., Li, C. C., DeWitt, S., & Muly, E. C. (2013) · The Journal of Comparative Neurology · doi:10.1002/cne.23435 · Cited by 5
Septotemporal Variation of Information Processing in the Hippocampus of Fmr1 KO Rat
Leontiadis, L. J., Felemegkas, P., Trompoukis, G., Tsotsokou, G., Miliou, A., Karagianni, E., Rigas, P., & Papatheodoropoulos, C. (2024) · Developmental Neuroscience · doi:10.1159/000537879 · Cited by 4
Shi, L., Kosti, A., Raj, N., Sun, J., Gao, Y., Simamora, R. C., Valdez‐Sinon, A. N., Faúndez, V., & Bassell, G. J. (2025) · iScience · doi:10.1016/j.isci.2025.113062 · Cited by 3
Self-citationAge-Dependent Regulation of Dendritic Spine Density and Protein Expression in Mir324 KO Mice
Parkins, E. V., Burwinkel, J. M., Ranatunga, R., Yaser, S., Hu, Y., Tiwari, D., & Groß, C. (2023) · Journal of Molecular Neuroscience · doi:10.1007/s12031-023-02157-4 · Cited by 3
Therapeutic approaches for the future treatment of Fragile X
Sastre, A., Campillo, N. E., Gil, C., & Martı́nez, A. (2015) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2015.01.003 · Cited by 2
Fragile X Syndrome: A Disorder of Synaptic Protein Synthesis Dynamics
Muddashetty, R. S., Nalavadi, V., & Bassell, G. J. (2012) · Journal of the Indian Institute of Science · Cited by 2
Self-citationGenetic and Pharmacological Reversibility of Phenotypes in Mouse Models of Autism Spectrum Disorder
Schroeder, J. C., Deliu, E., Novarino, G., & Schmeißer, M. J. (2017) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-319-52498-6_10 · Cited by 2
Ion Channel Dysfunction and FXS
Frick, A., Ginger, M. R., El‐Hassar, L., & Kaczmarek, L. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804461-2.00016-0 · Cited by 2
Pinheiro, M. M. L. S., Antunes, M. D., Carvalho, L. M. L., Pássaro, A. D. C., de Souza, I. M. B., Januário, P. D. O., Cruz, A. T., Lemes, R. B., Monfardini, F., & Marques, A. P. (2025) · Clinics · doi:10.1016/j.clinsp.2025.100758 · Cited by 1
Goel, A., Razak, K. A., Chubykin, A. A., & Antoine, M. W. (2025) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-025-09634-4 · Cited by 1
Unraveling the mechanisms of slack channel mutations in epileptic disorders
Wei, Y., Zahra, A., Wang, Q., & Wu, J. (2026) · Acta Epileptologica · doi:10.1186/s42494-026-00246-6 · Cited by 1
Functional and Molecular Diversity of Native Neuronal K + Channels
Nerbonne, J. M. (2016) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0000049 · Cited by 1
Fragile X Syndrome: From Pathophysiology to New Therapeutic Perspectives
D’Antoni, S., Spatuzza, M., Carmela, M., Aloisi, E., Musumeci, S. A., & Vincenza, M. (2012) · InTech eBooks · doi:10.5772/31387
Corrêa, J. D. C. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.41.2014.tde-01092014-085006
FMRP and the Pathophysiology of Fragile X Syndrome
Barnes, S. A., Thomson, S. R., Kind, P. C., & Osterweil, E. K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800109-7.00008-x
Post-transcriptional Regulation of Myelin Basic Protein Expression
Giampetruzzi, A. (2014) · OpenCommons at University of Connecticut (University of Connecticut)
Li, H., Choi, J. J.-Y., Huang, E. J., & Xu, B. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.09.663876
Kalinowska, M., van der Lei, M. B., Kitiashvili, M., Mamcarz, M., Oliveira, M. M., Longo, F., & Klann, E. (2022) · Figshare · doi:10.6084/m9.figshare.20193627
Kalinowska, M., van der Lei, M. B., Kitiashvili, M., Mamcarz, M., Oliveira, M. M., Longo, F., & Klann, E. (2022) · Figshare · doi:10.6084/m9.figshare.20193624
Alpha oscillations are dysrhythmic in Fragile X syndromePreprint
Siekierski, P., Liu, Y., Westerkamp, G. C., Elmaghraby, R., ElSayed, Z., Gilbert, D., Erickson, C. A., & Pedapati, E. V. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.30.702828
Moreno, C., Riquelme, D., Rio, C. A. C.-D., & Leiva‐Salcedo, E. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.03.703439
Sharma, G., Russell, A. L., Dixon, K. G., Fusha, R., & Triplett, J. W. (2026) · Open Biology · doi:10.1098/rsob.250269
Involvement of mGluR5/Homer crosstalk disruption in the pathophysiology of Fragile X Syndrome
Aloisi, E. (2015) · theses.fr (ABES) · doi:10.70675/e628d840zb6adz4e63z9d1fz71559b23fe24
Aidi-Knani, S. (2014) · theses.fr (ABES) · doi:10.70675/9bcb3ccfzbea9z4555z8ab9zebc1216c5e8b
The role of intrinsic neuronal excitability for Prelimbic network function
Sa, R. D. (2019) · theses.fr (ABES) · doi:10.70675/8b11b402z0ae7z4587z8084z65b59ce7ba62
Dissecting the role of calcium signaling in Fragile X syndrome
Castagnola, S. (2019) · theses.fr (ABES) · doi:10.70675/3d35096bz79d0z46edz8a70zb783a8f60257
Felgerolle, C. (2019) · theses.fr (ABES) · doi:10.70675/fbd5cf69zed5az4a57zbfdez48e26a937a72
Rôle de la phosphodiestérase 2A dans la physiopathologie du syndrome de l’X fragile
Delhaye, S. (2021) · theses.fr (ABES) · doi:10.70675/e0fac395z63d4z46a4z944aza4037215ca98
BKCa channels as therapeutic targets in neurodevelopmental disorders : focus on acoustic dysfunction
Ferraguto, C. (2024) · theses.fr (ABES) · doi:10.70675/38217611z1b01z43f4zb4b0z72d28aca79c3
Socio-communicative and nucleus accumbens core dysfunctions in fragile X syndrome
Giua, G. (2023) · theses.fr (ABES) · doi:10.70675/e45d048ez2538z4905zba74z1de16201406a
Reversing Pathophysiology in Fragile X Syndrome Mice by Promoting PGC-1α and Mitochondrial FunctionsPreprint
Acharya, A., Kumar, V., Lee, K. Y., Babik, M. S., Goswami, G., Boateng, K. A., Cyphersmith, A., Rhodes, J. S., & Tsai, N. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.13.718178
Luque, M. A., Dufresne, L., Torres, B., & Herrero, L. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.08.013
Malloy, C., Hu, J.-H., Liu, Y., Welch, M. A., Tsuda, M. C., Cameron, H. A., & Hoffman, D. A. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2611814123
Metadata
- Authors
- Gross, C., Yao, X., Pong, D. L., Jeromin, A., & Bassell, G. J.
- Affiliations
- Emory University (US)
- Banyan Biomarkers (United States) (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2011-04-13
- Volume
- 31
- Issue
- 15
- Pages
- 5693-5698
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC3089949
- OpenAlex
- W1992696632
- Cited by
- 161
- References
- 26
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 5 · 2023: 9 · 2022: 10 · 2021: 8 · 2020: 11 · 2019: 18 · 2018: 14 · 2017: 8 · 2016: 10 · 2015: 18 · 2014: 8 · 2013: 14 · 2012: 9
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (R01MH085617, MH085617)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P30HD024064)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- fragile X syndrome, FMRP, Kv4.2, voltage-gated potassium channels, neuronal hyperexcitability, MPEP, mRNA translation regulation, protein expression regulation, Fmr1 knockout mice, hippocampal excitability
- MeSH terms
- Actins, Animals, Dendrites, Fluorescent Antibody Technique, Mice, Inbred C57BL, Phenotype, Polyribosomes, RNA, Messenger, Seizures, Synapses, Protein Biosynthesis, Blotting, Western, DNA Primers, Receptors, Metabotropic Glutamate, Mice, Knockout, Biotinylation, 5' Untranslated Regions, 3' Untranslated Regions, Immunoprecipitation, Mice, Shal Potassium Channels, Fragile X Messenger Ribonucleoprotein 1, Fragile X Mental Retardation Protein, Receptor, Metabotropic Glutamate 5
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
